BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Class B Common Stock
Symbol
BIO on NYSE
Shares outstanding
5,071,025
Price per share
$303.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
19,455,647
Total reported value
$5,456,868,314
% of total 13F portfolios
0.01%
Share change
+263,666
Value change
+$100,299,139
Number of holders
386
Price from insider filings
$303.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SCHWARTZ NORMAN D 97% $1,382,052,897 4,929,036 Norman D. Schwartz 25 Sep 2025
SCHWARTZ ALICE N 12% $659,303,856 2,732,073 Alice N. Schwartz 01 May 2025
First Eagle Investment Management, LLC 11% +14% $657,060,173 +$60,827,513 2,528,321 +10% First Eagle Investment Management, LLC 30 Jun 2025
VANGUARD GROUP INC 8.4% $462,850,693 1,907,640 The Vanguard Group - 23-1945930 30 Sep 2024
BlackRock, Inc. 7.4% $453,705,832 1,618,123 BlackRock, Inc. 30 Sep 2025

As of 30 Sep 2025, 386 institutional investors reported holding 19,455,647 shares of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO). This represents 384% of the company’s total 5,071,025 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) together control 290% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
First Eagle Investment Management, LLC 50% 2,520,319 +0.12% 1.3% $706,672,287
VANGUARD GROUP INC 35% 1,793,537 -2.9% 0.01% $502,889,839
BlackRock, Inc. 33% 1,695,849 -3.8% 0.01% $475,499,107
DIMENSIONAL FUND ADVISORS LP 21% 1,062,938 +6.3% 0.06% $298,018,552
Veritas Asset Management LLP 17% 844,039 -2.2% 2.5% $236,660,095
ARIEL INVESTMENTS, LLC 16% 809,480 -1.1% 2.4% $226,970,097
EARNEST PARTNERS LLC 12% 609,284 +0.56% 0.74% $170,837,141
STATE STREET CORP 11% 571,599 -2.2% 0.01% $160,270,644
BANK OF AMERICA CORP /DE/ 9.1% 459,887 +1.7% 0.01% $128,947,715
Capital Research Global Investors 8.2% 418,355 0.02% $117,302,558
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 7.8% 397,171 +2271% 0.02% $111,362,776
First Pacific Advisors, LP 7.8% 394,414 +1.9% 1.5% $110,589,741
GEODE CAPITAL MANAGEMENT, LLC 6.9% 350,216 +4.8% 0.01% $98,213,875
PARNASSUS INVESTMENTS, LLC 6.2% 315,328 -0.6% 0.2% $88,414,818
SEI INVESTMENTS CO 5.6% 282,469 +6.4% 0.09% $79,199,024
Mawer Investment Management Ltd. 4.8% 243,468 -8.9% 0.35% $68,265,993
FULLER & THALER ASSET MANAGEMENT, INC. 4.7% 237,903 0.23% $66,705,645
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ 4.7% 237,254 -25% 3.4% $66,523,650
UBS Group AG 4.5% 230,719 +15% 0.01% $64,691,300
DEERFIELD MANAGEMENT COMPANY, L.P. 4.5% 226,070 0% 0.97% $63,387,767
NORTHERN TRUST CORP 4.5% 226,006 -0.22% 0.01% $63,369,823
THOMPSON SIEGEL & WALMSLEY LLC 4.3% 217,596 -29% 0.99% $61,012,000
GW&K Investment Management, LLC 3.6% 183,845 +25% 0.46% $51,550,000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 3.5% 179,966 -8.9% 0.01% $50,460,667
ROYAL BANK OF CANADA 3.5% 176,091 +16% 0.01% $49,374,000

Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 264,454 $80,495,827 +$3,599,428 $303.00 43
2025 Q3 19,455,647 $5,456,868,314 +$100,299,139 $280.39 386
2025 Q2 19,201,217 $4,634,744,932 +$3,469,914 $241.32 380
2025 Q1 19,188,664 $4,671,911,959 +$52,969,583 $243.56 429
2024 Q4 18,778,253 $6,169,336,505 -$215,682,627 $328.51 450
2024 Q3 19,370,183 $6,481,921,085 -$218,781,622 $334.58 433
2024 Q2 19,799,636 $5,407,155,613 +$314,233,620 $273.11 428
2024 Q1 18,483,713 $6,388,531,345 +$32,714,858 $345.87 456
2023 Q4 18,529,807 $5,981,150,118 -$116,305,124 $322.89 479
2023 Q3 18,786,490 $6,730,924,381 -$58,698,141 $358.45 466
2023 Q2 18,297,158 $6,935,982,346 -$192,100,378 $379.12 463
2023 Q1 19,221,018 $9,200,944,144 +$12,069,903 $479.02 499
2022 Q4 19,259,738 $8,110,380,673 -$117,736,871 $420.49 467
2022 Q3 19,487,538 $8,135,809,192 +$113,970,897 $417.14 471
2022 Q2 19,114,362 $9,462,174,468 +$34,485,329 $495.00 489
2022 Q1 19,167,385 $10,796,615,316 -$34,402,167 $563.23 505
2021 Q4 19,102,716 $14,417,922,909 -$389,707,592 $755.57 521
2021 Q3 19,387,789 $14,451,450,076 +$60,848,148 $745.95 500
2021 Q2 19,381,230 $12,476,219,166 -$119,629,052 $644.29 496
2021 Q1 19,617,764 $11,195,376,908 -$8,883,384 $571.17 483
2020 Q4 19,657,768 $11,449,028,308 +$302,277,766 $582.94 483
2020 Q3 19,264,413 $9,927,181,928 +$28,169,224 $515.46 471
2020 Q2 19,228,922 $8,674,553,754 +$210,745,728 $451.49 461
2020 Q1 18,823,652 $6,598,533,578 -$18,322,057 $350.56 400
2019 Q4 18,896,407 $6,990,274,305 -$73,846,893 $370.03 378
2019 Q3 19,229,050 $6,397,950,795 +$147,523,371 $332.74 349
2019 Q2 18,689,418 $5,839,484,014 -$162,235,104 $312.59 326
2019 Q1 19,427,855 $5,938,774,395 +$26,520,823 $305.68 340
2018 Q4 19,085,794 $4,431,741,573 -$63,728,134 $232.22 319
2018 Q3 18,915,230 $5,919,673,702 +$12,116,363 $312.99 336
2018 Q2 19,093,330 $5,509,358,014 -$50,946,485 $288.54 321
2018 Q1 19,293,335 $4,824,798,687 +$32,427,500 $250.08 310
2017 Q4 19,199,238 $4,582,088,596 +$7,406,998 $238.67 297
2017 Q3 19,186,971 $4,263,280,405 +$85,006,470 $222.22 268
2017 Q2 18,803,522 $4,255,482,844 -$40,486,301 $226.31 274
2017 Q1 19,038,767 $3,796,416,375 +$212,751,881 $199.34 270
2016 Q4 19,724,001 $3,595,615,783 +$105,010,927 $182.28 255
2016 Q3 19,083,435 $3,125,213,054 +$688,135 $163.81 235
2016 Q2 19,112,947 $2,733,970,889 +$70,361,251 $143.02 233
2016 Q1 18,593,481 $2,543,249,593 -$28,652,347 $136.72 227
2015 Q4 18,814,885 $2,609,135,116 -$16,649,584 $138.66 237
2015 Q3 18,827,519 $2,528,738,077 +$40,719,556 $134.31 241
2015 Q2 18,681,380 $2,812,961,739 -$21,728,607 $150.61 221
2015 Q1 18,867,726 $2,549,214,332 +$11,434,191 $135.18 216
2014 Q4 18,830,474 $2,270,334,287 +$17,595,205 $120.56 213
2014 Q3 18,587,460 $2,107,510,068 +$35,450,758 $113.40 198
2014 Q2 18,276,691 $2,186,453,716 +$17,844,667 $119.71 201
2014 Q1 18,092,627 $2,316,027,490 -$19,637,838 $128.12 189